Upon intra-peritumoral administration of CD80/86 + IL12 and OX40L mRNA-CARTs the mice showed a complete response at the treated tumor and systemic anti-tumor immune response, as seen by the regression of the untreated distal tumor [161]. This evidence concerns the gene CD80 and neoplasm.